Luxbright AB (publ) (LXB.ST)

Sweden · Healthcare · SEK

Key financials

ROE: -63.72%; 2025 (actual)
ROA: -46.97%; 2025 (actual)
Gross Margin: 84.92%; 2025 (actual)
Net Margin: -170.51%; 2025 (actual)
Total Assets: SEK 39,881.53K; 2025 (actual)
Net Income: -SEK 19,463.97K; 2025 (actual)
Valuation: SEK 108,573.24K; 2025 (actual)
Stock Price: SEK 44.82; 2025 (actual)

Historical & projected performance

Reported figures and Equlion model projections for the next 5 years.

Metric	2025 (actual)	2026	2027	2028	2029	2030
ROE	-63.72%	-142.76%	312.58%	82.17%	49.22%	34.78%
ROA	-46.97%	-58.09%	-64.94%	-69.48%	-72.69%	-73.65%
Gross Margin	84.92%	84.92%	84.92%	84.92%	84.92%	84.92%
Sector average	16.85%	17.71%	17.71%	17.71%	17.71%	17.71%
Net Margin	-170.51%	-170.13%	-169.43%	-169.74%	-169.61%

Amounts in SEK (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2025. Projections are model estimates, not investment advice.

Want the full financial forecast report for Luxbright AB (publ)? It covers the balance sheet, income statement and Equlion model projections.

Total Assets	SEK 39,881.53K	SEK 37,262.24K	SEK 39,549.42K	SEK 42,546.74K	SEK 45,416.28K	SEK 47,130.80K
Sector average	SEK 2,857,190.78K	SEK 2,900,240.60K	SEK 3,045,009.79K	SEK 3,280,286.42K	SEK 3,536,407.14K	SEK 3,762,908.71K

Net Income	-SEK 19,463.97K	-SEK 22,404.60K	-SEK 24,939.69K	-SEK 28,519.71K	-SEK 31,972.27K	-SEK 34,081.96K
Sector average	-SEK 2,851.32K	-SEK 22,027.28K	-SEK 904.69K	-SEK 7,253.84K	-SEK 3,858.45K	-SEK 1,547.00K

Valuation	SEK 108,573.24K	SEK 124,976.56K	SEK 139,117.69K	SEK 159,087.67K	SEK 178,346.60K	SEK 190,114.80K
Sector average	SEK 3,960,502.41K	SEK 5,151,301.60K	SEK 5,189,236.02K	SEK 5,317,343.69K	SEK 5,514,329.75K	SEK 5,636,782.17K

Stock Price	SEK 44.82	SEK 51.59	SEK 57.43	SEK 65.67	SEK 73.62	SEK 78.48
Sector average	SEK 57.22	SEK 48.04	SEK 48.69	SEK 50.45	SEK 52.13	SEK 53.41